chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARCEL
Symptoms: Pyrexia, Viral infection
Clinical narrative: Information has been received from a physician concerning a child from a day care who was vaccinated with a dose of varicella virus vaccine live. In February 2004, the patient presented with breakthrough chicken pox with less than 50 lesions and a fever. The patient was sent back to school. No further information was available. No product quality complaint was involved. It was also reported that 5 other children from the same day care were vaccinated with a dose of varicella virus vaccine live and also developed breakthrough chicken pox (WAES0403USA02248). Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Infection transmission via personal contact
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male patient who's 4 year old male classmate was vaccinated with a dose of varicella virus vaccine live in approximately January 2004. The vaccinee did not develop chicken pox nor rash. Around the same time in approximately January 2004, the patient developed shingles. The reporter questioned if this could have been a transmission case. Unspecified medical attention was sought. The reporter did not know if the patient had any follow up medical care. A product quality complaint was not involved. Additional information has been requested.
Age: 1.24
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old white female who on 10/5/99 was vaccinated with a dose of varicella virus vaccine live. On 3/29/04 the patient's mother called the physician's office and said that her child had a rash that looks like chicken pox. The rash began on 3/28/04 and the patient was expected to come into the office in the next few days for confirmation and follow up. There was no treatment outlined at the time of report. It was also noted that the patient was vaccinated at a different pediatrician's office so they did not have a lot number. Follow up information noted that the patient had unconfirmed chicken pox with about 30 lesions scattered over her entire body. She was placed on acyclovir cream. No diagnostic tests were performed. On 4/7/04 the patient recovered. No product quality complaint was involved. No further information is expected.
Age: 26.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a nurse practitioner concerning an otherwise healthy white 28 year old female resident physician with no past medical history and no known drug allergies who on 6/5/02 and 7/5/02 was vaccinated SC with the first (on the right) and second (on the left) doses of varicella virus vaccine live (lot # 639490/0574L). There  was no illness at the time of vaccination. In February 2004, the patient had a negative varicella titer. Unspecified medical attention was sought. There was no product quality complaint. Follow up information indicated that on 6/3/02 (pre-vaccination), the patient had a VZV blood test that showed she was non-immune. The patient was then given two doses of varicella virus vaccine live 30 days apart. On 2/24/04 (post-vaccination), the patient had a VZV blood test that was negative (presumed non-immune to varicella zoster virus). No further information is expected.
Age: 1.33
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 10 year old white female with no known allergies who on 1/2/95 was vaccinated with a dose of varicella virus vaccine live. It was reported that the patient's mom called on 3/25/04 to report that the patient started with chicken pox on 3/23/04. The mother was using aveno oatmeal bath and calamine lotion to the spots. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. The child presented to the clinic with a rash following vaccination. No treatment was required. It was noted that the vaccine was given elsewhere and that the reporter did not want to give any detailed information and commented that this happens (all the time). Unspecified medical attention was sought. There was no product quality complaint involved. No further information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Cerebellar ataxia
Clinical narrative: Information has been received from a physician concerning a 2 year old female with no past medical history who on approx 01Dec03 was vaccinated with varicella virus vaccine live (0.5ml) SC. There was no concomitant medication. On 17Mar04 the pt developed cerebellar ataxia. The spinal fluid had been sent and was being conducted to determine if a wild strain or vaccine strain was involved. The pt sought unspecified medical attention. The reporter considered cerebral ataxia to be disabling. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: IPV, VARCEL
Symptoms: Irritability, Pain, Pyrexia, Rash, Skin ulcer
Clinical narrative: Information has been received from a physician concerning a 4 year old white female patient with a history of paroxysmal supraventricular tachycardia (at 14 months and treated with propranolol hydrochloride for two years) who on 3/18/04 in the AM was vaccinated with a first dose of varicella virus vaccine live (647707/1245N), SC in the left thigh. Concomitant therapy on 3/18/04 included a fourth dose of poliovirus vaccine inactivated, IM. On 3/22/04 the patient developed a rash. On 3/25/04, the patient's lesions had grown to 80-100 on trunk, mouth, face, scalp, and had a slight fever. The patient was described as cranky and complained of pain in arm, legs, and throat. The patient recovered. It was also reported that at 15 months of age the patient developed a rash after vaccination with MMR (WAES0405USA01267). No further information is expected.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a certified medical assistant concerning a 4 year old female with an allergy to rubbing alcohol and no other relevant medical history who on 5/20/00 was vaccinated with a dose of varicella virus vaccine live (lot # 632057/1450J). There was no concomitant medication. On 3/26/04, the patient developed a rash of chicken pox on the face and neck and more on her skin. It was noted that the office did not specify where else on skin. The physician gave the patient cetirizine hydrochloride for the chicken pox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is expected.
Age: 1.01
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a physician concerning a 5 year old patient who on 5/18/99 was vaccinated with a dose of Varicella virus vaccine live (lot # 630034/0313J). The week of 3/29/04 the patient came to the physician's office with a moderate varicella rash with 20-30 lesions on the trunk and back. There was no fever. No product quality complaint was involved. Additional information has been requested.
Age: 0.98
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain, Pyrexia, Rash, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male, with no past medical history and no known drug allergies who on 4/3/97 was vaccinated SC in the left thigh with a first 0.5ml dose of varicella virus vaccine live (lot # 621071/1552D). There was no illness at the time of vaccination. On 3/30/03 the patient presented with a zoster like rash on his left buttock and left thigh. No other symptoms were noted. Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a registered nurse provided information that the patient's rash was noted by his mother on 3/28/04 (previously reported as 3/28/03). The patient presented to the office on 3/30/04, and at that time the rash was vesicular. It was noted to begin on the left buttocks and proceed in a dermatome fashion across the left thigh to the knee (also described  as from the left superior buttocks to the left medial malleolus across the anterior thigh to the knee and medial calf). There were many lesions too numerous to count. The rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. Herpes zoster was diagnosed on 3/30/04. The patient's maximum temperature was 98.9 degrees F. There were no other relevant diagnostic tests or laboratory data. The patient's pain was quantified at a 2 (with 0 being the least and 10 being the most). The were no other systemic symptoms. There was no history of chicken pox and there was no recent exposure to chicken pox or herpes zoster. A direct flurorescent antibody was not done. A specimen was not collected for PCR. No photo was taken. No fever and no other complaints were noted. The outcome was reported as recovered. No additional information is expected.
Age: 0.6
Sex: F
Vaccine: VARCEL
Symptoms: Rash pruritic, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a consumer concerning his girl friend's approximately 9 year old daughter who on 4/26/96 was vaccination SC in the left arm with a first dose of varicella virus vaccine live (lot # 617355/0567D). There was no illness at the time of vaccination. Subsequently the patient developed chicken pox, described as a very mild case with 15-20 lesions. The child did not develop a fever. She was treated with Aveno baths and calamine (+) camphor (+) lidocaine hydrochloride. No additional patient details were provided. Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a registered nurse indicated that the patient developed a pruritic rash on her legs, head, back, and belly for 6 days. The patient was diagnosed with attenuated varicella 8 years post vaccination. The reporter indicated that the was no adverse event. Additional follow up information indicated the adverse event onset was 3/29/04. It was noted that the patient recovered on 4/5/04. No further information is expected.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a medical assistant in a physician's office concerning a 6 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced breakthrough chicken pox. The case was reported to be mild. Unspecified medical attention was sought. A product quality complaint was not involved. No further information was available. The medical assistant also reported a male toddler who had a similar experience after therapy with varicella virus vaccine live (WAES0404USA00169).
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a doctor of pathology concerning a female who was vaccinated with a first and second dose of varicella virus vaccine live. It was reported that the patient failed to seroconvert. The physician stated that the infectious control department would handle the reporting of vaccine failure. Unspecified medical attention was sought. No further information is available.
Age: 1.02
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Skin ulcer, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 9 year old male with no past medical history and no known drug allergies who on 2/27/96 in the PM was vaccinated SC with a first dose of varicella virus vaccine live (lot # 612218/1128B). There was no illness at the time of vaccination. Concomitant therapy that day in the PM included a dose of MMR (lot # 614838/1428B). On 3/15/04 in the PM the patient developed a total of 88 lesions per report of the mother. Subsequently, the patient recovered on 3/22/04. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a physician concerning a 5 year old male patient who on 10/26/99 was vaccinated with a dose of varicella virus vaccine live. On 2/19/04, the patient was seen in the reporting physician's office because he had broken out with chicken pox and an onset date of 2/19/04 was noted. There were fifteen to twenty lesions, but the patient did not have a fever. The reporter described the patient's chicken pox as a mild case with very few lesions. The reporter stated there was no lab work and no hospitalization. Subsequently, the patient fully recovered. A product quality complaint was not involved. Additional information is not expected.
Age: 1.24
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a physician concerning a 7 year old healthy female who on 9/22/97 was vaccinated with a dose of varicella virus vaccine live (lot # 622851/0539E). The physician reported that on 3/29/04, the patient experienced breakthrough. Unspecified medical attention was sought, but no treatment was required. At the time of this report, the outcome was unknown. The physician also reported that another patient developed breakthrough after being vaccinated with varicella virus vaccine live (WAES0405USA00764). Additional information has been requested.
Age: 1.05
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a physician concerning a 12 month old female with no pertinent history except an intra-cranial hemorrhage at birth and a seizure disorder at birth and a exposure to shingles from her father 2 weeks prior to vaccination who on 3/26/04 at 2:15 PM was vaccinated SC with a first dose of varicella virus vaccine live (lot # 647253/1060N). There was no concomitant medication. It was also noted that on 5/16/2003 at 10:10 AM and on 7/11/03 at 2:27 PM, the patient was vaccinated IM with the first and second doses of HIB conjugate vaccine (lot # 647163/0917N). On 3/30/04 the patient presented to the physician's office with a really bad case of chicken pox all over her body. It was noted that the child did not have a fever at the time of the visit. The outcome was reported as not recovered. Unspecified medical attention was sought. There was no product quality complaint. Follow up information was received from a health professional indicated that the child developed breakthrough varicella virus on 3/30/03. The outcome was reported as recovered on 4/8/04. There were no adverse events following prior vaccinations for the patient. No further information is expected.
Age: 3.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Abnormal behaviour, Feeling cold, Pyrexia
Clinical narrative: Pt's dad noticed onset of fever on 4/15 to be around 102-103 degrees that evening. Started treating with children's Tylenol and Ibuprofen, cool bathes and fluids. Fever spiked 4/17 at 104.4 slight rash on chest, waist, legs noted per father, continued above treatment. 4/18 at 0500 fever 103.8  by 1000-98.8. While on phone at 1400 4/18. Dad mentioned pt to be chilled again. Recommended to continue treatments and notify MD if not better by 4/19. Father denies any breathing difficulties or seizure activity. Only silliness when fever spikes.
Age: 3.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Chills, Dizziness, Pyrexia, Rash
Clinical narrative: Pt's dad noticed onset of fever on 4/15 to be around 102-103 degrees that evening. Started treating with children's Tylenol and Ibuprofen, cool bathes and fluids. Fever spiked 4/17 at 104.4 slight rash on chest, waist, legs noted per father, continued above treatment. 4/18 at 0500 fever 103.8  by 1000-98.8. While on phone at 1400 4/18. Dad mentioned pt to be chilled again. Recommended to continue treatments and notify MD if not better by 4/19. Father denies any breathing difficulties or seizure activity. Only silliness when fever spikes.
Age: 1.42
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC, VARCEL, DTAP, HIBV, MMR, PNC, VARCEL, DTAP, HIBV, MMR, PNC, VARCEL
Symptoms: Dyskinesia, Eye movement disorder, Febrile convulsion, Hypoventilation, Pyrexia
Clinical narrative: Pt attended Immunization Clinic on 5-10-05.  No previous history of reactions noted, mother reports seizure activity noted in the evening and early morning following the immunizations.  Child seen at Hospital - treated & released.
Age: 1.42
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC, VARCEL, DTAP, HIBV, MMR, PNC, VARCEL, DTAP, HIBV, MMR, PNC, VARCEL
Symptoms: Convulsion
Clinical narrative: Pt attended Immunization Clinic on 5-10-05.  No previous history of reactions noted, mother reports seizure activity noted in the evening and early morning following the immunizations.  Child seen at Hospital - treated & released.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a RN who is the grandmother of a pt who about 2 years ago, in  approximately 2002 was vaccinated with a SC 0.5ml dose of varicella virus vaccine, live. Subsequently, the pt was getting over a "breakthrough case of varicella" No TX  was required. Unspecified medical attention was sought. There was no product quality complaint involved. At the time of the report the child was 5 years of age. The reported also mentioned another grandchild was vaccinated with a dose of varicella virus vaccine, live and experienced a simialr reaction. WAES 0405USA01744.  Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning an 8 year old male who in 1997, at the age of 12 months, was vaccinated with one dose of varicella virus vaccine live. On 3/31/04, the patient presented to his practice with small, bite-like lesions all over his trunk and extremities. On 4/1/04 the patient presented to the physician with a fever and small vesicular like lesions all over the trunk, buttocks, thighs, face, and mouth. It was reported that the patient had not yet recovered. No product quality complaint was involved. It was also noted that 3 years ago according to the mother's recollection, the patient was diagnosed with a subclinical case of varicella. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning an 11 year old male with Crohn's disease who on 5/12/00 was vaccinated with a dose of varicella virus vaccine live. Concomitant therapy included mesalamine. The physician reported that in approximately March 2004, the patient had varicella titers drawn which were negative. Unspecified medical attention was sought, but no treatment was required. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a medical assistant in a physician's office concerning a male toddler who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced breakthrough chickenpox. the case was reported to be mild. Unspecified medical attention was sought. A product quality complaint was not involved. No further information was available. The medical assistant also reported a 6 year old male who had a similar experience after therapy with varicella virus vaccine live (WAES0404USA00013).
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Pruritus, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old female with no past medical history and no known drug allergies who was vaccinated with a dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 3/17/04 at 11:40 AM, also reported as 4/28/04 at 11:00 AM, the patient developed blister type lesions on her back and abdomen. Otherwise, there was no distress. The rash was reported as being itchy, and the vesicular rash also involved the face. It was also noted that there were no adverse reactions. Subsequently, the patient recovered. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations of the patient or her siblings. Follow up information received from a registered nurse indicated that the patient had an outbreak of a rash only. No other symptoms were noted. The outcome was reported as recovered approximately 3-4 days after onset. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. No further information is expected.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male who on 1/19/01 was vaccinated with a dose of varicella virus vaccine live (lot number was unavailable). On 3/29/04, he was seen with shingles on the left arm and a few spots on his chest. No treatment was required. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles. No further information is expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning an 8 year old female who on 7/1/98 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 4/1/04 the patient developed 20-25 lesions. There were no diagnostic laboratory tests performed. It was noted that treatment was required and that the physician advised treatment with diphenhydramine HCl. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.69
Sex: M
Vaccine: DTP, VARCEL
Symptoms: Drug ineffective, Rash macular, Viral infection
Clinical narrative: Information has been received from a RN concerning a 9 year old healthy white male pt with no allergies and not past medical history who on 09/04/96, was vaccinated IM in the right thigh with a first dose of varicella virus vaccine, live. Concomitant vaccination on 09/04/1996 included a fourth dose IM in LL of diphtheria toxoid + pertussis vaccine + tetanus toxoid. There was no illness at the time of vaccination and there were no adverse events following prior vaccination. On 04/22/04. the pt presented to the office with approximately ten widely scattered macules with clear vesicles on the right shoulder, left foot and lower abdomen. There were no other sx. An onset date of 04/02/04 was noted. The pt was treated with oral acyclovir and OTC diphenhydramine hydrochloride lotion (Benadryl). Lab tests were not performed. Subsequently the pt recovered. A product quality complaint was not involved. Additional information is expected.
Age: 1.26
Sex: M
Vaccine: VARCEL
Symptoms: Skin ulcer, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an 9 year old male with allergies, seasonal rhinitis, and no other medical history who on 7/17/96 was vaccinated with a dose of varicella virus vaccine live (lot # 617075/1663B). Concomitant therapy included loratadine for seasonal rhinitis. The nurse reported that the patient now has breakthrough varicella. The symptoms started on 3/30/04. The patient was seen in the office on 4/1/04 with about 30 lesions generalized over the body. He was treated with diphenhydramine hydrochloride, and calamine lotion. It was noted that he was exposed to several cases of varicella at school. A product quality complaint was not involved. Additional information has been requested. The nurse also reported a 10 year old child who had a similar experience after therapy with varicella virus vaccine live (WAES0404USA01992) and five or six other children with similar experiences after therapy with varicella virus vaccine live.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male who was vaccinated on 6/23/00 with a dose of varicella virus vaccine live (lot # was unavailable). On 1/1/04, the patient was hospitalized for several days for lots of lesions. The child was noted to have breakthrough chicken pox. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435, and 0404USA00436). No further information is expected.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a RN concerning a 6 year old male who was vaccinated on 05/07/1998 with a dose of varicella virus vaccine, live. On 06/27/03, the pt was seen with skin lesions "all over" The child was noted to have  breakthrough chicken pox. Unspecfied medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other pt's were vaccinated with a dose of varicella virus vaccien live, and developed chickenpox breakthrough/ shingles(WAES # 0404USA00205, WAES # 0404USA00418, WAES # 0404USA00420, WAES# 0404USA00421, WAES # 0404USA00422, WAES # 0404USA00423, WAES # 0404USA00424, WAES # 0404USA00425, WAES # 0404USA00426, WAES # 0404USA00427, WAES # 0404USA00428, WAES # 0404USA00429,  WAES # 0404USA00430, WAES # 0404USA00431, WAES # 0404USA00432, WAES # 0404USA00433, WAES # 0404USA00434, WAES # 0404USA00435, AND WAES # 0404USA00436. No further information is expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Skin ulcer
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female who was vaccinated on 08/23/2002 with a dose of varicella virus vaccine live (Oka/Merck).  On 07/02/2003, the patient developed "breakthrough" with lesions on her groin and trunk.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old female who was vaccinated on 12/08/2000 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 06/12/2003 with a chickenpox breakthrough, described as a rash on her body for 2 days.  No therapy was required.  The outcome was reported as recovered.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who was vaccinated on 08/04/1999 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen in October 2003 with a rash on the right side of his face and cheek.  No therapy was required.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old female who was vaccinated on 07/19/2000 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 02/26/2004 with over 50 pox over his entire body.  No fever and no itching was noted.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning a 8 year old male who was vaccinated on 01/17/1996 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen in June 2003 with over 50 lesions on his body following a known exposure.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old female who was vaccinated on 09/13/1999 with a dose of varicella virus vaccine live (Oka/In August 2003, the patient was seen with a few lesions after a known exposure.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live.  No further information is expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Erythema, Infection, Rash
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male who was vaccinated on 05/31/2000 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen in November 2003 with a few red lesions. The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reported indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female who was vaccinated on 07/31/1996 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 03/31/2004 with a few pox on her trunk.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old male who was vaccinated on 01/07/1999 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 02/06/2003 with a prolonged breakout.  No other comments were provided.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was not product quality compliant.  No further information is expected.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old male who was vaccinated on 12/02/1997 with a doses of varicella virus vaccine live (Oka/Merck).  In October 2003 the patient was seen with a rash over his entire body.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality compliant.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female who was vaccinated on 07/02/1996 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen in December 2003 with spots on her trunk and face.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old male who was vaccinated on 04/26/1996 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 03/22/2004 with questionable chickenpox.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality compliant.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male who was vaccinated on 5/27/97 with a dose of varicella virus vaccine live (lot number was unavailable). The patient was seen in April 2003 with a few pox. The child was noted to have chicken pox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 040USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00433, 0404USA00434, 0404USA00435, and 0404USA00436). No further information is expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 8 year old male who was vaccinated on 5/31/96 with a dose of varicella virus vaccine live (lot number was unavailable). In April 2003, the patient had a few pox after a known exposure. The child was noted to have chicken pox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine life and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435, and 0404USA00436). No further information is expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old female who was vaccinated on 6/21/99 with a dose of varicella virus vaccine live (lot number was unavailable). The patient was seen in January 2004 with a few pox after exposure. The child was noted to have chicken pox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435, 0404USA00436). No further information is expected.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old male who was vaccinated on 10/1/01 with a dose of varicella virus vaccine live (lot number was unavailable). The patient was seen on 12/24/03 with pox on her legs, thighs, and back. No itching was noted. The child was noted to have chicken pox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00436). No further information is expected.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 11 year old male who was vaccinated on 12/7/95 with a dose of varicella virus vaccine live (lot number was unavailable). The patient was seen in June 2003 with pox. The child was noted to have chickenpox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435). No further information is expected.
Age: 1.02
Sex: M
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Blister, Pyrexia, Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male with a history of ear infection who on 5/28/03 was vaccinated IM in the right thigh with a first dose of varicella virus vaccine live (lot # 637676/0275M). Suspect vaccination included a first dose of MMR (lot # 639692/0635M) given IM in the right thigh. Concomitant vaccination included a fourth dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine (lot # 491188) given IM in the left thigh. There was no illness at the time of vaccination. On 4/4/04 (also reported as 4/5/04), the patient began to develop a rash on his face, neck and chest. On 4/5/04, the patient was seen in the office with a fever of 99.8 F and chicken pox blisters, which was reported as clinical chicken pox. It was noted that a clinical exam was performed. The physician prescribed calamine (+) camphor (+) diphenhydramine hydrochloride lotion, diphenhydramine hydrochloride (+) acetaminophen, and ibuprofen. It was reported that the patient had no adverse events following prior vaccination. There was no product quality complaint involved. Follow up information indicated that the patient recovered from chickenpox. No further information is available.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a consumer concerning her 9 year old daughter with no past medical history who on 10/25/96 was vaccinated with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. On 4/2/04, the patient developed a full blown case of chickenpox. The patient had hundreds of lesions. Unspecified medical attention was sought, but treatment was not required and laboratory tests were not performed. The reporter also noted that therapy with varicella virus vaccine live was discontinued. At the time of the report, the patient was much improved. It was also noted that the adverse event abated and the patient is recovering with sequelae. A product quality complaint was not involved. Additional information is not expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Viral infection
Clinical narrative: Information has been received from a consumer concerning her 8 year old daughter with no past medical history who in 1999 was vaccinated with a dose of varicella virus vaccine live (lot number not available). There was no concomitant medication. In approximately April 2004, the patient developed a mild case of chickenpox. Unspecified medical attention was sought, treatment was not required and laboratory tests were not performed. The reporter noted therapy with varicella virus vaccine live was discontinued. At the time of the report, the patient was getting better, but had not totally recovered. A product quality complaint was not involved. The reporter stated the physician may not be contacted. Additional information is not expected.
Age: 1.26
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old male student who on 2/24/99 was vaccinated with a dose of varicella virus vaccine live. It was noted, the patient's mother reported that on 3/30/04 in the PM the patient developed a chicken pox breakout and by 3/31/04 he had 35-40 lesions. Additional information has been requested. The registered nurse also reported that the patient's brother developed a chicken pox breakout following vaccination with varicella virus vaccine live (WAES0404USA00505).
Age: 1.15
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male student who on 4/16/97 was vaccinated with a dose of varicella virus vaccine live. It was noted, the patient's mother reported that on 3/17/04 the patient had developed a chicken pox breakout of approximately 40 lesions. No additional information is expected. The registered nurse also reported that the patient's brother also developed a chicken pox breakout following vaccination with varicella virus vaccine live (WAES0404USA00503).
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Rash, Viral infection
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old male student with no known drug allergies who on 9/29/99 was vaccinated SC on the left side with the first dose of varicella virus vaccine live (lot # 631176/0718J). It was reported that on 3/7/04, the patient developed scattered vesicles on his body. The patient was seen in a physician's office. On 3/8/04, the patient recovered. The reporter also mentioned the patient's sibling (WAES0404USA00508) who was also vaccinated with varicella virus vaccine live and experienced a similar reaction. Additional information is not expected.
Age: 1.31
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from office staff concerning a 7 year old male who on 7/30/97 was vaccinated SC on the left side with a dose of varicella virus vaccine live (lot # 622749/0544E). On 2/21/04, the patient developed a rash on the body for 48 hours. Unspecified medical attention was sought. It was unknown if the patient had recovered. The reporter also mentioned the patient's sibling (WAES0404USA00506) was was also vaccinated with varicella virus vaccine live and experienced a similar reaction. Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Dehydration, Glossodynia, Hyperaesthesia, Hypersensitivity, Laboratory test abnormal
Clinical narrative: Patient had severe skin reaction to RabAvert vaccine. Regimen stopped at this time due to full body ruby red rash with swollen tongue covered with white spots, tongue too sore to eat, skin sensitive to touch and sore throat. 5th dose of PEP regimen held for now. Follow up on 7/25/05: We completed the PEP Series for Rabies, albeit a couple of weeks late for the fifth dose with a dose of HDCV on an inpatient basis, EPI, and Benadryl ready in case of an allergic reactin. No reaction occurred. No subsequent problems from the fith dose to date. Information from medical records states dehydration. msv
Age: 49.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Leukocytosis, Oral intake reduced, Pharyngolaryngeal pain, Rash, Tongue oedema
Clinical narrative: Patient had severe skin reaction to RabAvert vaccine. Regimen stopped at this time due to full body ruby red rash with swollen tongue covered with white spots, tongue too sore to eat, skin sensitive to touch and sore throat. 5th dose of PEP regimen held for now. Follow up on 7/25/05: We completed the PEP Series for Rabies, albeit a couple of weeks late for the fifth dose with a dose of HDCV on an inpatient basis, EPI, and Benadryl ready in case of an allergic reactin. No reaction occurred. No subsequent problems from the fith dose to date. Information from medical records states dehydration. msv
Age: 49.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Rash, Vaccine positive rechallenge
Clinical narrative: Patient had severe skin reaction to RabAvert vaccine. Regimen stopped at this time due to full body ruby red rash with swollen tongue covered with white spots, tongue too sore to eat, skin sensitive to touch and sore throat. 5th dose of PEP regimen held for now. Follow up on 7/25/05: We completed the PEP Series for Rabies, albeit a couple of weeks late for the fifth dose with a dose of HDCV on an inpatient basis, EPI, and Benadryl ready in case of an allergic reactin. No reaction occurred. No subsequent problems from the fith dose to date. Information from medical records states dehydration. msv
Age: 52.0
Sex: M
Vaccine: FLUX
Symptoms: Cough, Pyrexia
Clinical narrative: Coughing, and Fever
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Feeling hot, Injection site mass, Injection site oedema, Laboratory test abnormal
Clinical narrative: Information has been received from a 24 year old female pt, who is a RN, who on an unk date was vaccinated with a first dose of varicella virus vaccine live. After that initial information with varicella virus vaccine live, she was found to have a negative titer. On an unspecified date in approx Apr 2005, the pt was vaccinated with a second dose of varicella virus vaccine live. After receipt of the second dose, the injection site became swollen, hard and hot to touch. Medical attention was sought and she was treated with an antibiotic. It was reported that the pt recovered on an unk date. There was no product quality complaint reported. Swollen, hard and a hot to touch injection site were considered to other important medical events by the reporter (OMIC). Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Heart rate decreased, Muscle twitching
Clinical narrative: Approximately 5-10 minutes after receiving the Menactra vaccine, she became light headed. The mother helped her to lay down. Mother noticed some twitching which lasted 10 seconds. P 40 BPM and regular BP 120/60. BP remained normal and pulse increased over the next 10 minutes. Drank some water, felt better and went home accompanied by her mother. Sent for EKG, EEG, CMP, Neuro and Cardio consult.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Apnoea, Convulsion
Clinical narrative: 2 weeks after Pediarix administration, patient had several seizures; seen in clinic. Called apnea. Vax given 4/29/05. Hospitalized 5/11/05.